Effect of intravenous high-dose methylprednisolone on coagulation and fibrinolysis markers [2]

Thrombosis and Haemostasis

Volumn 94, Issue 2, 2005, Pages 467-468

  Frank, Rolf Dario ^a   Altenwerth, Björn ^a   Brandenburg, Vincent M ^a   Nolden Koch, Martina ^a   Block, Frank ^a,b  

^a UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^b HELIOS KLINIKEN SCHWERIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; ANTIPLASMIN; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR 8; DALTEPARIN; FIBRINOGEN; FRAGMIN P; METHYLPREDNISOLONE; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR 1; PREDNISONE; PROCOAGULANT; PROTHROMBIN; THROMBIN ANTITHROMBIN COMPLEX; TISSUE PLASMINOGEN ACTIVATOR; VON WILLEBRAND FACTOR;

ADULT; AGED; BLOOD CLOTTING; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DRUG MECHANISM; DRUG MEGADOSE; DRUG PULSE THERAPY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBRINOLYSIS; HEMATOCRIT; HUMAN; LETTER; MALE; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STEROID THERAPY; THROMBOSIS;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; BLOOD COAGULATION; BLOOD COAGULATION FACTORS; BLOOD COAGULATION TESTS; FACTOR VIII; FEMALE; FIBRINOGEN; FIBRINOLYSIS; HUMANS; INFUSIONS, INTRAVENOUS; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MULTIPLE SCLEROSIS; PREDNISONE; RISK FACTORS; THROMBOEMBOLISM; TIME FACTORS; VON WILLEBRAND FACTOR;

EID: 23744445107     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (16)

1. Cosgriff SW. Thromboembolic complications associated with ACTH and cortisone therapy. JAMA 1951; 147: 924-6.
2. Sjöberg HE, Blombäck M, Granberg PO. Thromboembolic complications, heparin treatment and increase in coagulation factors in Cushing's syndrome. Acta Med Scand 1976; 199: 95-8.
3. Wadman B, Werner I. Thromboembolic complications during corticosteroid treatment of temporal atteritis. Lancet 1972; i: 907.
4. Albucher JF, Vuillemin-Azais C, Manelfe C et al. Cerebral thrombophlebitis in three patients with probable multiple sclerosis. Cerebrovasc Dis 1999; 9: 298-303.
5. Stolz E, Klöstzsch C, Schlachetzki F et al. High-dose corticosteroid treatment is associated with an increased risk of developing cerebral venous thrombosis. Eur Neurol 2003; 49: 247-8.
6. Drescher W, Weigert KP, Bunger MH et al. Femoral head blood flow reduction and hypercoagulability under 24 h megadose steroid treatment in pigs. J Orthoped Res 2004; 22: 501-8.
7. McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 2001; 50: 121-7.
8. Fatti LM, Bottasso B, Invitti C et al. Markers of activation of coagulation and fibrinolysis in patients with Cushing's syndrome. J Endocrinol Invest 2000; 23: 145-50.
9. Patrassi GM, Sartori MT, Viero ML et al. The fibrinolytic potential in patients with Cushing's disease: a clue to their hypercoagulable state. Blood Coagul Fibrinolysis 1992; 3: 789-93.
10. Vandenberghe N, Debouverie M, Anxionnat R et al. Cerebral venous thrombosis in four patients with multiple sclerosis. Eur J Neurol 2003; 10: 63-6.
11. Oner AF, Gurgey A, Kirazli S et al. Changes of hemostatic factors in children with acute lymphoblastic leukemia receiving combined chemotherapy including high dose methylprednisolone and L-asparaginase. Leuk Lymphoma 1999; 33: 361-4.
12. Mall V, Thomas KB, Sauter S et al. Effect of glucocorticoids, E.coli- and Erwinia L-asparaginase on hemostatic proteins in children with acute lymphoblastic leukemia. Klin Padiatr 1999; 211: 205-10.
13. Sevaljevic L, Macvanin M, Zakula Z et al. Adrenalectomy and dexamethasone treatment alter the patterns of basal and acute phase response-induced expression of acute phase protein genes in rat liver. J Steroid Biochem Mol Biol 1998; 66: 347-53.
14. Kraaijenhagen RA, in't Anker PS, Koopman MMW et al. Highplasma concentration of factor VIIIc is a major risk factor for venous thromboembolism. Thromb Haemost 2000; 83: 5-9.
15. Koster T, Blann AW, Briet E et al. Role of clotting factor VIII in effect of von Willebrand factor on occurrence of deep vein thrombosis. Lancet 1995; 345: 152-5.
16. Patrassi GM, Sartori-MT, Livi U et al. Impairment of fibrinolytic potential in long-term steroid treatment after heart transplantation. Transplantation 1997; 64: 1610-13.